Fuda Hospital
- Brachytherapy is one of the primary prostate cancer treatment options at Fuda as far as its doctors focus on non-surgical therapy for oncology.
- A 10-year survival rate is achieved by Fuda doctors after prostate cancer treatment.
- Fuda is a unique hospital in China that successfully treats patients with cancer stages 3-4.
- The medical center is accredited by JCI (Joint Commission International). This is a certificate that confirms the world-class quality of medical services.
Submit a request to receive a personalized brachy treatment price for prostate cancer at Fuda.